OTCMKTS:PBIO Pressure BioSciences (PBIO) Stock Price, News & Analysis → Catalyst Could Trigger 10,000% Crypto Gains (From Crypto 101 Media) (Ad) Free PBIO Stock Alerts $0.15 0.00 (0.00%) (As of 06/17/2024 ET) Add Compare Share Share Today's Range$0.14▼$0.1550-Day Range$0.13▼$0.3052-Week Range$0.13▼$0.83Volume21,307 shsAverage Volume48,969 shsMarket Capitalization$5.18 millionP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock AnalysisChartEarningsFinancialsHeadlinesSEC FilingsShort InterestStock AnalysisChartEarningsFinancialsHeadlinesSEC FilingsShort Interest Get Pressure BioSciences alerts: Email Address Ad Weiss RatingsRadical change coming — do this NOW to protect yourselfI recently uncovered a way the government could use the next crisis as a pretext to gain more control … and radically change life in America as we know it today. And a Draconian set of technologies that could impose a new kind of financial surveillance in America. Click here to learn more. About Pressure BioSciences Stock (OTCMKTS:PBIO)Pressure BioSciences, Inc. develops and sells pressure-based platform solutions in the North America, Europe, and Asia. The company's pressure cycling technology (PCT) technology uses alternating cycles of hydrostatic pressure between ambient and ultra-high levels to control the actions of molecules in biological samples, including cells and tissues from human, animal, plant, and microbial sources. It offers Barocycler instrumentations comprising Barocycler 2320EXT, Barocycler HUB880, Barocycler HUB440, and the Shredder SG3. The company also distributes cell disruption equipment, parts, and consumables. In addition, it offers Barocycler consumable products, such as PCT MicroTubes, PCT MicroCaps, PCT-Micro Pestle, and pressure used to lyse samples for extraction tubes, as well as application specific kits, including consumable products and reagents. The company serves researchers at academic laboratories, government agencies, biotechnology companies, pharmaceutical firms, and other life science institutions. It has collaborations with RedShiftBio Inc.; Inova Schar Cancer Center; NYU; Leica Microsystems, GmbH; Steinbeis Centre for biopolymer analysis and biological mass spectrometry; The Ohio State University; University of Delaware; and Cedars Sinai Medical Center. The company was formerly known as Boston Biomedica, Inc. and changed its name to Pressure BioSciences, Inc. in September 2014. The company was incorporated in 1978 and is based in South Easton, Massachusetts.Read More PBIO Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart PBIO Stock News HeadlinesJune 18 at 8:16 AM | globenewswire.comPressure BioSciences, Inc. to Host Business and Financial Update on Thursday, June 20th at 4:30pm ETJune 13, 2024 | globenewswire.comPressure BioSciences, Inc. to Host Business and Financial Update on Wednesday, June 19th at 4:30pm ETJune 18, 2024 | Priority Gold (Ad)Biden to Launch “FedNOW” [Move Your Money Now]Earlier this year President Biden signed the death warrant for America… Executive Order 14067 will essentially cancel your money. You see Biden and the Fed have teamed up to create a controllable, traceable, programmable digital currency to replace the dollar...April 24, 2024 | bbc.co.ukThe big blood pressure experimentApril 22, 2024 | msn.comPacBio moved to Neutral at JPMorgan after guidance cutApril 2, 2024 | finance.yahoo.comPressure BioSciences’ Uncle Bud’s Subsidiary Reports Significant Demand for New UltraShear CBD Body Revive Spray – First Product in New “Premium Collection”April 2, 2024 | globenewswire.comPressure BioSciences' Uncle Bud's Subsidiary Reports Significant Demand for New UltraShear CBD Body Revive Spray – First Product in New “Premium Collection”March 25, 2024 | nytimes.comThe Best Pressure WasherJune 18, 2024 | Behind the Markets (Ad)Bigger Than NVIDIA?With NVIDIA flying high, everyone is looking for the next breakout stock. But right now... There's only ONE stock you should be watching.March 5, 2024 | nypost.comThe 8 best blood pressure monitors, approved by expertsFebruary 26, 2024 | globenewswire.comUncle Bud's Health & Wellness Experiencing Powerful Growth One Month Following Acquisition by Pressure BioSciences, Inc.February 23, 2024 | benzinga.comPressure BioSciences Stock (OTC:PBIO) Insider TradesFebruary 15, 2024 | finance.yahoo.comPressure BioSciences Completes Relocation into New Manufacturing Facility, Consolidating R&D with Expanded UltraShear Equipment Development and Contract ManufacturingFebruary 15, 2024 | globenewswire.comPressure BioSciences Completes Relocation into New Manufacturing Facility, Consolidating R&D with Expanded UltraShear Equipment Development and Contract ManufacturingFebruary 6, 2024 | forbes.comWrist Blood Pressure Monitors: Are They Accurate?February 5, 2024 | forbes.comBest Blood Pressure Monitors For 2024February 5, 2024 | finance.yahoo.comUncle Bud’s to Launch New Premium Health and Wellness Products Leveraging Pressure BioSciences UltraShear Processing for Revolutionary Product EffectivenessJanuary 26, 2024 | msn.comPressure Biosciences Acquires Uncle Bud’s AssetsJanuary 22, 2024 | finance.yahoo.comPressure BioSciences Announces Closing of Uncle Bud’s Acquisition in All-Stock Transaction, Completing UltraShear Nanoemulsions Forward Integration with World Class Marketing & SalesJanuary 20, 2024 | benzinga.comPressure BioSciences Stock (OTC:PBIO) Dividends: History, Yield and DatesJanuary 16, 2024 | finance.yahoo.comPressure BioSciences’ New Consumer Products Unit Continues Long Sales Relationship with Dominant U.S. Retailer, Launching 2024 with Quarter Million Dollar Shipment in JanuaryJanuary 15, 2024 | benzinga.comToni Braxton Cheers PBIO's Acquisition Of Cannabis And Hemp Co. Uncle Bud'sJanuary 12, 2024 | theglobeandmail.comHemp-CBD Market Demand Gaining Momentum While Projected to Reach $16 Billion By 2025January 11, 2024 | markets.businessinsider.comPressure BioSciences To Acquire Uncle Bud's - Quick FactsJanuary 4, 2024 | finance.yahoo.comPressure BioSciences’ BaroFold Platform Expected to Revolutionize Biopharmaceutical Production with Help from New Computational (AI/ML) TechnologiesDecember 21, 2023 | finance.yahoo.comPressure BioSciences' Celebrates Second Groundbreaking Article Published This Month on its Transformative, Patented UltraShear Technology Processing PlatformDecember 12, 2023 | finance.yahoo.comPressure BioSciences’ UltraShear Platform Maintains Nutritional, Sensory, and Other Important Qualities of Liquid Foods While Inactivating Foodborne Bacterial SporesSee More Headlines Receive PBIO Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Pressure BioSciences and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings6/07/2024Today6/18/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeOTCMKTS SectorMedical Industry Analytical instruments Sub-IndustryN/A Current SymbolOTCMKTS:PBIO CUSIPN/A CIK830656 Webwww.pressurebiosciences.com Phone508-230-1828Fax508-230-1829Employees16Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)($1.62) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-29,310,000.00 Net Margins-1,482.05% Pretax Margin-1,482.00% Return on EquityN/A Return on Assets-1,792.42% Debt Debt-to-Equity RatioN/A Current Ratio0.02 Quick Ratio0.01 Sales & Book Value Annual Sales$1.98 million Price / Sales2.62 Cash FlowN/A Price / Cash FlowN/A Book Value($1.29) per share Price / Book-0.11Miscellaneous Outstanding Shares35,490,000Free Float31,654,000Market Cap$5.18 million OptionableNot Optionable Beta-0.21 Ten Starter Stocks For Beginners to Buy NowJust getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.Get This Free Report Key ExecutivesMr. Richard T. Schumacher (Age 74)Founder, President, CEO, Treasurer, Interim CFO, Clerk & Director Comp: $320.54kDr. Edmund Y. Ting Ph.D. (Age 69)Sc.D. Ph.D., Senior Vice President of Engineering Comp: $215.16kDr. Alexander V. Lazarev Ph.D. (Age 59)Vice President of Research & Development Comp: $202.27kJohn B. HollisterDirector of Sales & MarketingKey CompetitorsTalis BiomedicalNASDAQ:TLISAstrotechNASDAQ:ASTCScientific IndustriesOTCMKTS:SCNDPrecipioNASDAQ:PRPOCue HealthNASDAQ:HLTHView All Competitors PBIO Stock Analysis - Frequently Asked Questions How have PBIO shares performed in 2024? Pressure BioSciences' stock was trading at $0.33 at the beginning of the year. Since then, PBIO shares have decreased by 55.8% and is now trading at $0.1460. View the best growth stocks for 2024 here. Are investors shorting Pressure BioSciences? Pressure BioSciences saw a increase in short interest in May. As of May 31st, there was short interest totaling 26,500 shares, an increase of 516.3% from the May 15th total of 4,300 shares. Based on an average trading volume of 66,900 shares, the short-interest ratio is presently 0.4 days. View Pressure BioSciences' Short Interest. How were Pressure BioSciences' earnings last quarter? Pressure BioSciences, Inc. (OTCMKTS:PBIO) released its earnings results on Friday, June, 7th. The company reported ($0.30) earnings per share for the quarter. The business had revenue of $0.31 million for the quarter. What other stocks do shareholders of Pressure BioSciences own? Based on aggregate information from My MarketBeat watchlists, some companies that other Pressure BioSciences investors own include Advanced Micro Devices (AMD), Allena Pharmaceuticals (ALNA), Actinium Pharmaceuticals (ATNM), Anavex Life Sciences (AVXL), Aware (AWRE), Curaleaf (CURLF) and Walt Disney (DIS). How do I buy shares of Pressure BioSciences? Shares of PBIO stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (OTCMKTS:PBIO) was last updated on 6/18/2024 by MarketBeat.com Staff From Our PartnersBigger Than NVIDIA?With NVIDIA flying high, everyone is looking for the next breakout stock. But right now... There's only ...Behind the Markets | SponsoredBeta testers blew this thing upThis AI trading tool is probably unlike anything you've ever seen before… It scans the entire market and fi...Prosper Trading Academy | SponsoredThe ONE AI Stock to own now. (It’s not Nvidia.)Don’t panic — you haven’t missed the boat on AI. In fact, it has barely launched. Sure, the early stages...Weiss Ratings | SponsoredElon Musk: THIS will be bigger than TeslaIf you missed out on crypto, this could be your second chance. The AI “wealth window” is opening now, but you ...Paradigm Press | SponsoredThe Scary Fed Idea To Turn Your Dollars Into a Digital Power GrabCash is becoming a relic of the past… Soon, Biden and the Federal Reserve plan to replace the dollar with t...Oasis Gold | SponsoredBiden Nomination CANCELED?And I believe when they do take the oath of office, their fingers will be crossed… and America will descend in...The Freeport Society | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Pressure BioSciences, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Pressure BioSciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.